Colgate-Palmolive Co (CL) concluded trading on Thursday at a closing price of $85.68, with 4.54 million shares of worth about $389.01 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.54% during that period and on February 06, 2025 the price saw a loss of about -1.09%. Currently the company’s common shares owned by public are about 817.01M shares, out of which, 815.78M shares are available for trading.
Stock saw a price change of -5.73% in past 5 days and over the past one month there was a price change of -2.12%. Year-to-date (YTD), CL shares are showing a performance of -5.75% which increased to 1.89% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $82.68 but also hit the highest price of $109.30 during that period. The average intraday trading volume for Colgate-Palmolive Co shares is 4.80 million. The stock is currently trading -2.60% below its 20-day simple moving average (SMA20), while that difference is down -5.89% for SMA50 and it goes to -10.98% lower than SMA200.
Colgate-Palmolive Co (NYSE: CL) currently have 817.01M outstanding shares and institutions hold larger chunk of about 84.48% of that.
The stock has a current market capitalization of $70.00B and its 3Y-monthly beta is at 0.40. PE ratio of stock for trailing 12 months is 24.41, while it has posted earnings per share of $3.51 in the same period. Its PEG reads 3.84 and has Quick Ratio of 0.65 while making debt-to-equity ratio of 37.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CL, volatility over the week remained 1.74% while standing at 1.63% over the month.
Stock’s fiscal year EPS is expected to rise by 3.14% while it is estimated to increase by 8.06% in next year. EPS is likely to grow at an annualized rate of 6.35% for next 5-years, compared to annual growth of 5.01% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on October 28, 2024 offering a Hold rating for the stock and assigned a target price range of between $105 and $101 to it. Coverage by Piper Sandler stated Colgate-Palmolive Co (CL) stock as an Overweight in their note to investors on September 24, 2024, suggesting a price target of $121 for the stock. On September 16, 2024, Wells Fargo Downgrade their recommendations, while on September 09, 2024, Deutsche Bank Downgrade their ratings for the stock with a price target of $109. Stock get a Hold rating from HSBC Securities on July 26, 2024.
